Skip to main content
Erschienen in: World Journal of Urology 7/2022

Open Access 06.06.2022 | Original Article

Urinary stone composition in Germany: results from 45,783 stone analyses

verfasst von: Roswitha Siener, Helena Herwig, Jakob Rüdy, Reinhold M. Schaefer, Philipp Lossin, Albrecht Hesse

Erschienen in: World Journal of Urology | Ausgabe 7/2022

Abstract

Purpose

Stone composition can provide valuable information for the diagnosis, treatment and recurrence prevention of urolithiasis. The aim of this study was to evaluate the distribution of urinary stone components and the impact of different crystal forms according to gender and age of patients in Germany.

Methods

A total of 45,783 urinary stones submitted from 32,512 men and 13,271 women between January 2007 and December 2020 were analyzed by infrared spectroscopy. Only the first calculus obtained per patient was included in the analysis.

Results

The most common main stone component was calcium oxalate (CaOx) (71.4%), followed by carbonate apatite (CA) (10.2%) and uric acid (UA) (8.3%). Struvite (2.1%), brushite (1.3%), protein (0.5%) and cystine (0.4%) stones were only rarely diagnosed. CaOx (75%) and UA stones (81%) were more frequently obtained from men than women (p < 0.001). Weddellite (COD) and uric acid dihydrate (UAD) were more common in younger ages than whewellite (COM) and anhydrous uric acid (UAA), respectively, in both men and women. The ratios of COM-to-COD and UAA-to-UAD calculi were approximately 4:1 and 8:1, respectively. The peak of stone occurrence was between the ages of 40 and 59 years.

Conclusion

Stone composition is strongly associated with gender and age. The peak incidence of calculi in both women and men was in the most active phase of their working life. The distinction between different crystal forms could provide clues to the activity and mechanisms of lithogenesis. Further research is needed in understanding the causative factors and the process of stone formation.
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1007/​s00345-022-04060-w.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

Urolithiasis is among the most common urologic diseases and imposes a significant burden on the healthcare system [1, 2]. The prevalence of urinary stone disease is estimated to be nearly 5% in Germany and 10% in the United States [3, 4]. Despite the availability of excellent treatment modalities, the recurrence rate of urinary stones is reported to be up to 50% after 10 years [3, 5]. Exact compositional stone analysis is the most important laboratory diagnostic procedure and a crucial prerequisite for an effective treatment and recurrence prevention of urolithiasis [68].
Previous studies on the distribution of urinary stone types in different countries revealed that calcium oxalate (CaOx) was the most frequent stone constituent followed by carbonate apatite (CA) and uric acid (UA) [911]. CaOx occurs in two different hydrate forms, whewellite (calcium oxalate monohydrate; COM) and weddellite (calcium oxalate dihydrate; COD). Due to its hardness, COM calculi are considered to respond poorly to disintegration by ESWL [12]. Likewise, UA can be present in two crystal species, anhydrous uric acid (UAA) and uric acid dihydrate (UAD) [13]. Although distinguishing between different hydrate forms may have implications for stone therapy and could provide valuable information about the etiology of stone formation, data on the occurrence and characteristics of COM, COD, UAA and UAD are scarce. While a single study based on 27,980 calculi reported on the distribution of COM and COD by sex and age [9], data on gender and age-related aspects of UAA and UAD are lacking. Therefore, data from 45,783 stone analyses were collected with the aim of evaluating the distribution of urinary stone components and different crystal forms according to age and gender of patients.

Materials and methods

Stone analyses

In total, 45,783 urinary stones submitted for analysis to the Urinary Stone Analysis Center Bonn and the University Stone Center of the Department of Urology, University Hospital Bonn, from 2007 to 2020 were evaluated. Urinary stone samples were obtained from all over Germany. Stones were collected after spontaneous passage, surgery, chemolysis, lithotripsy or instrumental procedures. To avoid overestimation of any stone type by multiple stones from the same patient, only the first calculus obtained per patient was included in the analysis. Patients with incomplete data in terms of age or sex were excluded from the study.
Each stone was analyzed using a standard operating procedure. The stones were dried at 37 °C and then crushed into a fine, homogenized powder using an agate mortar. Analysis was performed by Fourier transform infrared spectroscopy (FTIR) (Perkin Elmer, Waltham, MA, USA). The evaluation of the percentage of stone constituents was performed by comparing the graphs of the stone samples to a computerized library of reference spectra of single and mixed constituents. Each evaluation was examined by qualified and trained personnel and double-checked to ensure an accurate analysis. Laboratory quality certification was available for stone analysis. The FTIR technique is currently considered as the gold standard for routine clinical analysis of stone composition [10].

Stone classification

Mineral components accounting from 5% (weight-%) were counted. Stones containing a majority of > 50% of a single constituent were classified as such. Calculi without a main component > 50% were classified as being mixed. Stones containing any brushite were placed in the brushite group. Stones containing any cystine were classified as cystine. Materials unlikely having an origin in the human urinary tract, such as cellulose or wax, were classified as artifacts.

Statistical analyses

Categorical variables are presented as percentages. The effect of age and gender on different stone types was assessed by the Chi-squared test. Fisher’s exact test was used if the Chi-squared test was not applicable. The significance level was considered as p < 0.05. Statistical analysis was performed using SPSS for Windows, version 27.

Results

Stone composition

Of the 45,783 urinary stones included in the analysis, 71.4% were composed mostly of CaOx, followed by CA (10.2%) and UA (8.3%) (Table 1). Struvite (2.1%), brushite (1.3%), protein (0.5%), cystine (0.4%) and urate (0.3%) stones were only rarely diagnosed. Only four 2,8-dihydroxyadenine stones were submitted. In total, 56 samples contained silicate, 28 samples consisted of calcite, 16 stones contained drug metabolites and 46 samples were classified as artifacts. A total of 2216 stones (4.8%) were mixed stones containing no majority of a component.
Table 1
Distribution of stone components (n = 45,783)
Main component
Total number
%
Men number
%
Women number
%
p
M/F
Calcium oxalates
        
 Whewellite
26,017
56.8
19,518
60.0
6499
49.0
 < 0.001
3.00
 Weddellite
6685
14.6
4921
15.1
1764
13.3
 < 0.001
2.79
Phosphates
        
 Carbonate apatite
4649
10.2
2214
6.8
2435
18.3
 < 0.001
0.91
 Brushite
585
1.3
429
1.3
156
1.2
0.231
2.75
 Struvite
959
2.1
415
1.3
544
4.1
 < 0.001
0.76
 Other phosphates
163
0.4
65
0.2
98
0.7
 < 0.001
0.66
Uric acid and urates
        
 Uric acid anhydrous
3390
7.4
2755
8.5
635
4.8
 < 0.001
4.34
 Uric acid dihydrate
414
0.9
344
1.1
70
0.5
 < 0.001
4.91
 Ammonium urate
83
0.2
49
0.2
34
0.3
0.022
1.44
 Sodium/potassium urate
38
0.1
28
0.1
10
0.1
0.858
2.80
Protein
        
 Protein
245
0.5
158
0.5
87
0.7
0.029
1.82
Genetically determined stones
        
 Cystine
189
0.4
120
0.4
69
0.5
0.028
1.74
 2,8-Dihydroxyadenine
4
0.01
2
0.02
2
0.01
0.330
1.00
 Xanthine
0
0
0
Others
        
 Artifacts
46
0.1
28
0.1
18
0.1
0.141
1.56
 Silicate
56
0.1
29
0.1
27
0.2
0.002
1.07
 Calcite
28
0.1
15
0.05
13
0.1
0.058
1.15
 Drugs
16
0.03
10
0.05
6
0.03
0.422
1.67
Without main component
        
 Without main component
2216
4.8
1412
4.3
804
6.1
 < 0.001
1.76
Total
45,783
100
32,512
100
13,271
100
 < 0.001
2.45
P value for comparison between genders
M/F male-to-female ratio

Gender

The majority of stones was obtained from men (71.0%) as opposed to women (29.0%) resulting in a male-to-female ratio of 2.45 (Table 1). CaOx (75.1% versus 62.3%) was the most common main component in both men and women, followed by CA (18.3%), UA (5.3%) and struvite (4.1%) in women and by UA (9.6%) and CA (6.8%) in men. CaOx (75%) and UA stones (81%) were more frequently obtained from men than women (p < 0.001). Of CaOx and UA stones, COM (79.9% and 78.7%, respectively) and UAA (88.9% and 90.1%, respectively) were substantially more common than COD (20.1% and 21.3%, respectively) and UAD (11.1% and 9.9%, respectively) stones in men and women.

Age

The peak incidence of stones in both women (42.4%) and men (46.3%) were between the ages of 40 and 59 years, although this age group comprised only 30% of the general population in Germany [14] (supplementary Table 1). Age trends in stone distribution were similar in both genders for most stone types (Fig. 1a–c). CaOx was the most common main stone component in both genders and all age groups. While COD was second most frequently obtained from patients < 10 years old, COM was the relatively predominant main stone constituent between 20 and 89 years of age in both genders. The occurrence of UA stones increased strongly in men and women ≥ 60 years old, whereas CA stones were more frequently observed in patients under 40 years of age. Struvite stones were most common in the youngest and oldest age groups.
The percentage age distribution of different stone constituents in both genders is shown in Fig. 2a–c. Of the two hydrate forms of CaOx, COD was more frequent in women < 40 years old and in men < 50 years of age (Fig. 2a). In men, the peak incidence of COD stones occurred ten years earlier compared to COM. Of the two crystal forms of UA, an earlier age peak of UAD of ten years was observed in women and a higher occurrence in men < 69 years (Fig. 2b). The age peak of CA stones was between 30 and 39 years in both men and women (Fig. 2c). The maximum occurrence of brushite stones was between 30 and 39 years in men and between 30 and 59 years in women.

Discussion

Accurate compositional stone analysis using a reliable laboratory method is a crucial basis for effective diagnosis and treatment of urolithiasis [6, 7]. The distribution of stone components, the frequency of different hydrate forms and the impact of demographic factors could provide additional information about the etiology, therapy and recurrence prevention of stone disease. The current study presents the most recent data of urinary stone characteristics in Germany. CaOx was the most common main stone constituent in both genders, with 71.4% of all submitted calculi. The incidence of CaOx stones was higher in men. The current data confirm the high proportion of CaOx stones and the preponderance of men reported in other large series of patients [911]. Unfortunately, in a previous large series of stone analyses in Germany, calcium-containing calculi were not differentiated into CaOx and calcium phosphate stones [15].
The current study provided the largest database to date of urinary stones distinguishing between age and gender-related aspects of both hydrate forms of CaOx. The majority of COM and COD was obtained from men, corresponding to the greater incidence of CaOx stones in men. COM occurred substantially more frequent compared to COD stones with a ratio of approximately 4:1 in both genders. Moreover, COD was more common than COM until young adulthood in both genders, resulting in an earlier age peak, whereas the proportion of COM was higher in older age groups. A higher proportion of COM compared to COD stones in both genders and a preponderance of COD in younger age groups has also been reported in a prior study based on 27,980 calculi [9], while other large series of patients did not differentiate between COM and COD [10, 11]. The distinction between COM and COD may point to possible formation conditions of the two hydrate forms of CaOx. The propensity to develop COM or COD has been related to specific urinary risk factors. Several studies suggested that hyperoxaluria could contribute to the formation of COM [16, 17], while hypercalciuria might favor the formation of COD [1618]. The decline in the frequency of COD calculi with increasing age has been explained with a decrease in calcium excretion with age [9, 19]. However, no correlation of calcium excretion with age was observed in a recent study of 993 CaOx stone-forming patients [20]. Moreover, a previous study of stone patients found urine chemistry of limited value in distinguishing COM from COD stones [21].
Another explanation for the high ratio of COM-to-COD could be the formation process of the two hydrate forms of CaOx. Thermodynamically, COM is the more stable crystal form, whereas COD is metastable and is considered as the primary phase of CaOx stone formation [13, 22]. The conversion of COD to COM in urinary stones has been demonstrated convincingly [13, 22, 23]. Evidence suggests that CaOx stones undergo repeated events of dissolution and recrystallization during growth within the kidney [23, 24]. These findings might also explain a higher detection of COM with progressive age. It is hypothesized that COD stone formation at younger age possibly occurs due to a fast emerging process with a lack of time for dissolution and recrystallization processes. Urinary inhibitors that hinder remodelling processes at younger ages or promotors that initiate transition processes in older age are also conceivable. Osteopontin, an inhibitor of CaOx stone formation, has been reported to modify CaOx crystallisation kinetics towards the formation of COD rather than COM [25]. Decreasing blood levels of osteopontin with age could favour higher COD proportions with increasing age [26].
In the present study, CA was the second most common stone type in the German population. Both men and women were more susceptible to CA stones at younger ages. These findings are consistent with other studies [911]. The causes of CA stone formation include distal renal tubular acidosis, primary hyperparathyroidism and vitamin D supplementation [27]. Although urinary tract infection is not a prerequisite for the formation of CA stones, an infection component associated with alkaline urine favors CA stone formation [27]. Characteristic infection stones, i.e. struvite stones, were only rarely observed in this study, but were most frequent in the youngest and oldest age groups. Factors that predispose to urinary tract infections are, among others, vesicoureteral reflux in children and indwelling urinary catheter in the elderly.
UA stones were the second most common stones in men and the third most frequent stone type in women. UA calculi became more common with increasing age. Previous studies reported a similar age trend [911, 15]. Changes in renal function associated with aging, particularly diminishing urine pH [28], might increase urine supersaturation with UA. Furthermore, the increasing prevalence of overweight and insulin resistance is associated with more acidic urine and UA stones [29]. To our knowledge, the present study provided the first results of UA stones distinguishing between gender and age-related aspects of the two hydrate forms of uric acid. UAA stones were substantially more common than UAD calculi with a ratio of approximately 8:1. The only large series of patients to date that differentiated between the two crystalline forms of UA also reported a higher proportion of UAA compared to UAD stones [9]. UAD is exceedingly unstable and is frequently the primary phase of the formation of UA calculi [13]. A similar dehydration process to that described for the two hydrate forms of CaOx has been suggested for the transformation of UAD into the more stable UAA [13, 23].
Exact compositional stone analysis can provide essential information about factors affecting stone formation. The current study presented the largest series of stone analyses to date on the distribution of the different hydrate forms according to age and gender of patients. The distinction between the different hydrate forms of CaOx and UA in stone analysis in the present study is an important step to understanding the specific circumstances of their formation conditions. The formation mechanisms of the different crystal species must be verified to establish effective measures for the treatment and recurrence prevention of these types of stone. Further research is needed in understanding the causative and driving factors and the process of stone formation.
The study has a potential limitation. Clinical data of the patients were not available, other than age, gender, and the referral site submitting the stone. Nevertheless, the very large number of stone analyses available for this report provided valuable information on the distribution of urinary stone types and on sex and age-related predispositions to stone formation. Since the current data confirmed the frequency of the most common stone types reported in previous studies, it can be assumed that the results of the present study, especially on the different hydrate forms of calcium oxalate and uric acid, can be generalized to countries other than Germany. This largest series of stone analyses to date differentiating between age and gender-related aspects of different hydrate forms of stone constituents should give clues to the mechanisms and activity of the process of stone formation.

Conclusion

The most common stones in Germany were CaOx, followed by CA and UA. The peak incidence of stones was between the ages of 40 and 59 years of patients, i.e., in the most active phase of their working life. A clear predominance of COM and UAA over COD and UAD, respectively, was observed in both genders. The distinction between different crystal forms could provide clues to the activity and mechanisms of the lithogenic process. Understanding the mechanisms of stone formation is crucial for appropriate individualized treatment and recurrence prevention of each patient.

Declarations

Conflict of interest

The authors declare no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent is not applicable in this study.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Gynäkologie

Kombi-Abonnement

Mit e.Med Gynäkologie erhalten Sie Zugang zu CME-Fortbildungen der beiden Fachgebiete, den Premium-Inhalten der Fachzeitschriften, inklusive einer gedruckten gynäkologischen oder urologischen Zeitschrift Ihrer Wahl.

e.Med Urologie

Kombi-Abonnement

Mit e.Med Urologie erhalten Sie Zugang zu den urologischen CME-Fortbildungen und Premium-Inhalten der urologischen Fachzeitschriften.

Anhänge

Supplementary Information

Below is the link to the electronic supplementary material.
Literatur
1.
Zurück zum Zitat Ziemba JB, Matlaga BR (2017) Epidemiology and economics of nephrolithiasis. Investig Clin Urol 58:299–306CrossRef Ziemba JB, Matlaga BR (2017) Epidemiology and economics of nephrolithiasis. Investig Clin Urol 58:299–306CrossRef
2.
Zurück zum Zitat Geraghty RM, Jones P, Herrmann TRW, Aboumarzouk O, Somani BK (2018) Ureteroscopy is more cost effective than shock wave lithotripsy for stone treatment: systematic review and meta-analysis. World J Urol 36:1783–1793CrossRef Geraghty RM, Jones P, Herrmann TRW, Aboumarzouk O, Somani BK (2018) Ureteroscopy is more cost effective than shock wave lithotripsy for stone treatment: systematic review and meta-analysis. World J Urol 36:1783–1793CrossRef
3.
Zurück zum Zitat Hesse A, Brändle E, Wilbert D, Köhrmann KU, Alken P (2003) Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000. Eur Urol 44:709–713CrossRef Hesse A, Brändle E, Wilbert D, Köhrmann KU, Alken P (2003) Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000. Eur Urol 44:709–713CrossRef
4.
Zurück zum Zitat Chewcharat A, Curhan G (2021) Trends in the prevalence of kidney stones in the United States from 2007 to 2016. Urolithiasis 49:27–39CrossRef Chewcharat A, Curhan G (2021) Trends in the prevalence of kidney stones in the United States from 2007 to 2016. Urolithiasis 49:27–39CrossRef
5.
Zurück zum Zitat Tiselius HG (2016) Metabolic risk-evaluation and prevention of recurrence in stone disease: does it make sense? Urolithiasis 44:91–100CrossRef Tiselius HG (2016) Metabolic risk-evaluation and prevention of recurrence in stone disease: does it make sense? Urolithiasis 44:91–100CrossRef
7.
Zurück zum Zitat Williams JC, Gambaro G, Rodgers A, Asplin J, Bonny O, Costa-Bauzá A, Ferraro PM, Fogazzi G, Fuster DG, Goldfarb DS, Grases F, Heilberg IP, Kok D, Letavernier E, Lippi G, Marangella M, Nouvenne A, Petrarulo M, Siener R, Tiselius HG, Traxer O, Trinchieri A, Croppi E, Robertson WG (2021) Urine and stone analysis for the investigation of the renal stone former: a consensus conference. Urolithiasis 49:1–16CrossRef Williams JC, Gambaro G, Rodgers A, Asplin J, Bonny O, Costa-Bauzá A, Ferraro PM, Fogazzi G, Fuster DG, Goldfarb DS, Grases F, Heilberg IP, Kok D, Letavernier E, Lippi G, Marangella M, Nouvenne A, Petrarulo M, Siener R, Tiselius HG, Traxer O, Trinchieri A, Croppi E, Robertson WG (2021) Urine and stone analysis for the investigation of the renal stone former: a consensus conference. Urolithiasis 49:1–16CrossRef
9.
Zurück zum Zitat Daudon M, Dore JC, Jungers P, Lacour B (2004) Changes in stone composition according to age and gender of patients: a multivariate epidemiological approach. Urol Res 32:241–247CrossRef Daudon M, Dore JC, Jungers P, Lacour B (2004) Changes in stone composition according to age and gender of patients: a multivariate epidemiological approach. Urol Res 32:241–247CrossRef
10.
Zurück zum Zitat Lieske JC, Rule AD, Krambeck AE, Williams JC, Bergstralh EJ, Mehta RA, Moyer TP (2014) Stone composition as a function of age and sex. Clin J Am Soc Nephrol 9:2141–2146CrossRef Lieske JC, Rule AD, Krambeck AE, Williams JC, Bergstralh EJ, Mehta RA, Moyer TP (2014) Stone composition as a function of age and sex. Clin J Am Soc Nephrol 9:2141–2146CrossRef
11.
Zurück zum Zitat Zhang S, Huang Y, Wu W, He Z, Ou LL, Tiselius HG, Zeng G, Wu W (2021) Trends in urinary stone composition in 23,182 stone analyses from 2011 to 2019: a high-volume center study in China. World J Urol 39:3599–3605CrossRef Zhang S, Huang Y, Wu W, He Z, Ou LL, Tiselius HG, Zeng G, Wu W (2021) Trends in urinary stone composition in 23,182 stone analyses from 2011 to 2019: a high-volume center study in China. World J Urol 39:3599–3605CrossRef
12.
Zurück zum Zitat Dretler SP, Polykoff G (1996) Calcium oxalate stone morphology: fine tuning our therapeutic distinctions. J Urol 155:828–833CrossRef Dretler SP, Polykoff G (1996) Calcium oxalate stone morphology: fine tuning our therapeutic distinctions. J Urol 155:828–833CrossRef
13.
Zurück zum Zitat Hesse A, Berg W, Bothor C (1979) Scanning electron microscopic investigations on the morphology and phase conversions of uroliths. Int Urol Nephrol 11:11–20CrossRef Hesse A, Berg W, Bothor C (1979) Scanning electron microscopic investigations on the morphology and phase conversions of uroliths. Int Urol Nephrol 11:11–20CrossRef
14.
Zurück zum Zitat Statistisches Bundesamt (Destatis), Genesis-Online; Tabelle Nr. 12411–0006; Abrufdatum: 21.02.2022; Datenlizenz by-2–0; eigene Berechnungen Statistisches Bundesamt (Destatis), Genesis-Online; Tabelle Nr. 12411–0006; Abrufdatum: 21.02.2022; Datenlizenz by-2–0; eigene Berechnungen
15.
Zurück zum Zitat Knoll T, Schubert AB, Fahlenkamp D, Leusmann DB, Wendt-Nordahl G, Schubert G (2011) Urolithiasis through the ages: data on more than 200,000 urinary stone analyses. J Urol 185:1304–1311CrossRef Knoll T, Schubert AB, Fahlenkamp D, Leusmann DB, Wendt-Nordahl G, Schubert G (2011) Urolithiasis through the ages: data on more than 200,000 urinary stone analyses. J Urol 185:1304–1311CrossRef
16.
Zurück zum Zitat Daudon M, Réveillaud RJ (1984) Whewellite and weddellite: vers des étiopathogénies différentes. Intérêt du typage morphologique des calculs. Nephrologie 5:195–201PubMed Daudon M, Réveillaud RJ (1984) Whewellite and weddellite: vers des étiopathogénies différentes. Intérêt du typage morphologique des calculs. Nephrologie 5:195–201PubMed
17.
Zurück zum Zitat Bamberger JN, Blum KA, Kan KM, Parkhomenko E, Gallante B, Gupta M (2019) Clinical and metabolic correlates of calcium oxalate stone subtypes: implications for etiology and management. J Endourol 33:755–760CrossRef Bamberger JN, Blum KA, Kan KM, Parkhomenko E, Gallante B, Gupta M (2019) Clinical and metabolic correlates of calcium oxalate stone subtypes: implications for etiology and management. J Endourol 33:755–760CrossRef
18.
Zurück zum Zitat Brinkman JE, Large T, Nottingham CU, Stoughton C, Krambeck AE (2021) Clinical and metabolic correlates of pure stone subtypes. J Endourol 35:1555–1562CrossRef Brinkman JE, Large T, Nottingham CU, Stoughton C, Krambeck AE (2021) Clinical and metabolic correlates of pure stone subtypes. J Endourol 35:1555–1562CrossRef
19.
Zurück zum Zitat Costa-Bauzá A, Ramis M, Montesinos V, Conte A, Pizá P, Pieras E, Grases F (2007) Type of renal calculi: variation with age and sex. World J Urol 25:415–421CrossRef Costa-Bauzá A, Ramis M, Montesinos V, Conte A, Pizá P, Pieras E, Grases F (2007) Type of renal calculi: variation with age and sex. World J Urol 25:415–421CrossRef
20.
Zurück zum Zitat Tran TVM, Li X, Adams-Huet B, Maalouf NM (2021) Impact of age and renal function on urine chemistry in patients with calcium oxalate kidney stones. Urolithiasis 49:495–504CrossRef Tran TVM, Li X, Adams-Huet B, Maalouf NM (2021) Impact of age and renal function on urine chemistry in patients with calcium oxalate kidney stones. Urolithiasis 49:495–504CrossRef
21.
Zurück zum Zitat Asplin JR, Lingeman J, Kahnoski R, Mardis H, Parks JH, Coe FL (1998) Metabolic urinary correlates of calcium oxalate dihydrate in renal stones. J Urol 159:664–668CrossRef Asplin JR, Lingeman J, Kahnoski R, Mardis H, Parks JH, Coe FL (1998) Metabolic urinary correlates of calcium oxalate dihydrate in renal stones. J Urol 159:664–668CrossRef
22.
Zurück zum Zitat Hesse A, Berg W, Schneider HJ, Hienzsch E (1976) A contribution to the formation mechanism of calcium oxalate urinary calculi. II. In vitro experiments concerning the theory of the formation of whewellite and weddellite urinary calculi. Urol Res 4:157–160CrossRef Hesse A, Berg W, Schneider HJ, Hienzsch E (1976) A contribution to the formation mechanism of calcium oxalate urinary calculi. II. In vitro experiments concerning the theory of the formation of whewellite and weddellite urinary calculi. Urol Res 4:157–160CrossRef
23.
Zurück zum Zitat Leusmann DB, Meyer-Jürgens UB, Kleinhans G (1984) Scanning electron microscopy of urinary calculi—some peculiarities. Scan Electron Microsc 3:1427–1432 Leusmann DB, Meyer-Jürgens UB, Kleinhans G (1984) Scanning electron microscopy of urinary calculi—some peculiarities. Scan Electron Microsc 3:1427–1432
24.
Zurück zum Zitat Sivaguru M, Saw JJ, Williams JC, Lieske JC, Krambeck AE, Romero MF et al (2018) Geobiology reveals how human kidney stones dissolve in vivo. Sci Rep 8:13731CrossRef Sivaguru M, Saw JJ, Williams JC, Lieske JC, Krambeck AE, Romero MF et al (2018) Geobiology reveals how human kidney stones dissolve in vivo. Sci Rep 8:13731CrossRef
25.
Zurück zum Zitat Wesson JA, Johnson RJ, Mazzali M, Beshensky AM, Stietz S, Giachelli C, Liaw L, Alpers CE, Couser WG, Kleinman JG, Hughes J (2003) Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules. J Am Soc Nephrol 14:139–147CrossRef Wesson JA, Johnson RJ, Mazzali M, Beshensky AM, Stietz S, Giachelli C, Liaw L, Alpers CE, Couser WG, Kleinman JG, Hughes J (2003) Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules. J Am Soc Nephrol 14:139–147CrossRef
26.
Zurück zum Zitat Nourkami-Tutdibi N, Graf N, Beier R, Zemlin M, Tutdibi E (2020) Plasma levels of osteopontin from birth to adulthood. Pediatr Blood Cancer 67:e28272CrossRef Nourkami-Tutdibi N, Graf N, Beier R, Zemlin M, Tutdibi E (2020) Plasma levels of osteopontin from birth to adulthood. Pediatr Blood Cancer 67:e28272CrossRef
27.
Zurück zum Zitat Hesse A, Heimbach D (1999) Causes of phosphate stone formation and the importance of metaphylaxis by urinary acidification: a review. World J Urol 17:308–315CrossRef Hesse A, Heimbach D (1999) Causes of phosphate stone formation and the importance of metaphylaxis by urinary acidification: a review. World J Urol 17:308–315CrossRef
28.
Zurück zum Zitat Berkemeyer S, Vormann J, Günther ALB, Rylander R, Frassetto LA, Remer T (2008) Renal net acid excretion capacity is comparable in prepubescence, adolescence, and young adulthood but falls with aging. J Am Geriatr Soc 56:1442–1448CrossRef Berkemeyer S, Vormann J, Günther ALB, Rylander R, Frassetto LA, Remer T (2008) Renal net acid excretion capacity is comparable in prepubescence, adolescence, and young adulthood but falls with aging. J Am Geriatr Soc 56:1442–1448CrossRef
29.
Zurück zum Zitat Abate N, Chandalia M, Cabo-Chan AV, Moe OW, Sakhaee K (2004) The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int 65:386–392CrossRef Abate N, Chandalia M, Cabo-Chan AV, Moe OW, Sakhaee K (2004) The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int 65:386–392CrossRef
Metadaten
Titel
Urinary stone composition in Germany: results from 45,783 stone analyses
verfasst von
Roswitha Siener
Helena Herwig
Jakob Rüdy
Reinhold M. Schaefer
Philipp Lossin
Albrecht Hesse
Publikationsdatum
06.06.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 7/2022
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-022-04060-w

Weitere Artikel der Ausgabe 7/2022

World Journal of Urology 7/2022 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.